Who owns GENMAB A/S?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GMAB from SEC Form 13F filings across 332 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 332 institutions disclosed 133.2M shares of GENMAB A/S worth $4.81B — about 21.7% of shares outstanding; the largest disclosed holder is Darwin Global Management, Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
332
13F holders
$4.81B
value, 2026 filers
21.7%
of shares outstanding (133.2M sh)
79
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of GMAB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Darwin Global Management, Ltd.NEW | 17.9M | $638.6M | 16.0% | 2.9% | new |
| 2 | Paradigm Biocapital Advisors LP | 14.1M | $504.3M | 10.0% | 2.3% | +7.6% |
| 3 | Orbis Allan Gray Ltd | 10.6M | $377.0M | 1.3% | 1.7% | -7.0% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 6.9M | $244.9M | 3.8% | 1.1% | 0.0% |
| 5 | ALLIANCEBERNSTEIN L.P. | 6.4M | $228.4M | 0.1% | 1% | -25.9% |
| 6 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 6.1M | $216.5M | 0.1% | 1% | +22.0% |
| 7 | BlackRock, Inc. | 6.1M | $216.1M | 0.0% | 1% | +29.7% |
| 8 | TWO SIGMA INVESTMENTS, LP | 5.3M | $187.4M | 0.1% | 0.9% | +49.8% |
| 9 | Sofinnova Investments, Inc. | 4.3M | $155.2M | 6.7% | 0.7% | +7.5% |
| 10 | Deep Track Capital, LP | 4.2M | $149.2M | 2.4% | 0.7% | -26.0% |
| 11 | Capital World InvestorsNEW | 3.9M | $139.2M | 0.0% | 0.6% | new |
| 12 | Point72 Asset Management, L.P. | 3.5M | $126.1M | 0.1% | 0.6% | +2506.1% |
| 13 | FIRST TRUST ADVISORS LP | 3.2M | $115.1M | 0.1% | 0.5% | +17.0% |
| 14 | Harding Loevner LP | 2.9M | $134.2M | 1.5% | 0.5% | -6.0% |
| 15 | Holocene Advisors, LPNEW | 2.3M | $82.6M | 0.2% | 0.4% | new |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 2.3M | $81.1M | 0.1% | 0.4% | -35.4% |
| 17 | CITADEL ADVISORS LLC | 1.7M | $61.7M | 0.0% | 0.3% | -30.2% |
| 18 | MORGAN STANLEY | 1.7M | $61.2M | 0.0% | 0.3% | +5.2% |
| 19 | Alyeska Investment Group, L.P. | 1.7M | $59.9M | 0.2% | 0.3% | +108.6% |
| 20 | FRANKLIN TEMPLETON INC | 1.5M | $82.5M | 0.0% | 0.2% | +24.5% |
| 21 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 1.4M | $49.9M | 0.1% | 0.2% | new |
| 22 | FEDERATED HERMES, INC. | 1.2M | $44.2M | 0.1% | 0.2% | -14.5% |
| 23 | MARSHALL WACE, LLP | 1.2M | $43.5M | 0.0% | 0.2% | +47.0% |
| 24 | GOLDMAN SACHS GROUP INC | 1.2M | $42.6M | 0.0% | 0.2% | -6.6% |
| 25 | Pictet Asset Management Holding SA | 1.2M | $41.0M | 0.0% | 0.2% | +8.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.